IPCA Laboratories Ltd. (IPCALAB)

Volume: 35,980Avg Vol 1W: 86,602Avg Vol 1M: 1,74,47352W Range:₹1,251.6₹1,678.3

NSE BSE

₹1,538.7▼ 0.74%

Key Ratios

Updated just now

Market Cap₹40,232 Cr

Current Price₹1,538.7

Previous Close₹1,550.2

High / Low (52w)₹1,678.3 / ₹1,251.6

Volume35,980

Avg Vol (1W)86,602

Avg Vol (1M)1,74,473

Stock P/E51.63

Book Value₹317.85

Dividend Yield0.38%

ROE14.15%

ROA9.63%

Revenue (TTM)—

Revenue Growth16.02%

Profit Margin11.83%

Total Debt₹543 Cr

Shares Outstanding25 Cr

Face Value₹1

EPS (TTM)₹13.31

P/B4.83

Debt / Equity0.1

50 DMA₹1,587.35

200 DMA₹1,519.93

Day change-0.74%

Price Chart

₹1,538.7▲ 20.95% · 1Y

2025-10-20

2026-06-16

20-day avg volume: 1.8L shares

Pros

Company is almost debt-free.
Revenue grew 15% YoY.
Net profit is growing year over year.

Cons

Stock trades at a high P/E of 52.

Quarterly Results

Metric	Mar 2026	Dec 2025	Sept 2025	Jun 2025	Mar 2025	Dec 2024	Sept 2024	Jun 2024	Mar 2024	Dec 2023	Sept 2023	Jun 2023	Mar 2023	Dec 2022	Sept 2022	Jun 2022	Mar 2022	Dec 2021	Sept 2021	Jun 2021	Mar 2021	Dec 2020	Sept 2020	Jun 2020	Mar 2020
Revenue	₹2,388 Cr	₹2,393 Cr	₹2,557 Cr	₹2,309 Cr	₹2,247 Cr	₹2,245 Cr	₹2,355 Cr	₹2,093 Cr	₹2,033 Cr	₹2,053 Cr	₹2,034 Cr	₹1,585 Cr	₹1,512 Cr	₹1,546 Cr	₹1,601 Cr	₹1,586 Cr	₹1,289 Cr	₹1,430 Cr	₹1,544 Cr	₹1,566 Cr	₹1,115 Cr	₹1,410 Cr	₹1,361 Cr	₹1,534 Cr	₹1,074 Cr
EBITDA	₹470 Cr	₹446 Cr	₹469 Cr	₹349 Cr	₹355 Cr	₹385 Cr	₹367 Cr	₹314 Cr	₹243 Cr	₹254 Cr	₹309 Cr	₹283 Cr	₹148 Cr	₹180 Cr	₹233 Cr	₹230 Cr	₹173 Cr	₹261 Cr	₹327 Cr	₹382 Cr	₹196 Cr	₹329 Cr	₹324 Cr	₹549 Cr	₹118 Cr
Net Profit	₹299 Cr	₹326 Cr	₹283 Cr	₹233 Cr	₹68 Cr	₹248 Cr	₹229 Cr	₹192 Cr	₹60 Cr	₹180 Cr	₹145 Cr	₹163 Cr	₹77 Cr	₹108 Cr	₹144 Cr	₹143 Cr	₹130 Cr	₹196 Cr	₹250 Cr	₹307 Cr	₹161 Cr	₹265 Cr	₹267 Cr	₹446 Cr	₹86 Cr
EPS	11.79	12.86	11.14	9.19	2.67	9.78	9.05	7.58	2.35	7.09	5.72	6.42	3.02	4.25	5.67	5.64	5.13	7.76	19.73	24.18	12.71	21.09	21.11	35.24	6.57

Profit & Loss (Annual)

Metric	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020
Revenue	₹9,032 Cr	₹7,830 Cr	₹6,370 Cr	₹5,896 Cr	₹5,483 Cr	₹4,686 Cr
EBITDA	₹1,421 Cr	₹1,089 Cr	₹791 Cr	₹1,143 Cr	₹1,398 Cr	₹763 Cr
Net Profit	₹738 Cr	₹547 Cr	₹471 Cr	₹884 Cr	₹1,140 Cr	₹606 Cr
EPS	29.08	21.57	18.58	34.85	45.01	47.73

Balance Sheet

Metric	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020
Total Assets	₹11,761 Cr	₹11,101 Cr	₹8,626 Cr	₹7,624 Cr	₹6,068 Cr	₹5,260 Cr
Total Liabilities	₹3,372 Cr	₹3,374 Cr	₹2,711 Cr	₹2,082 Cr	₹1,352 Cr	₹1,619 Cr
Equity	₹8,388 Cr	₹7,727 Cr	₹5,915 Cr	₹5,542 Cr	₹4,716 Cr	₹3,641 Cr
Total Debt	₹543 Cr	₹580 Cr	₹652 Cr	₹395 Cr	₹9 Cr	₹103 Cr

Cash Flow

Metric	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020
Operating	₹1,683 Cr	₹1,241 Cr	₹1,029 Cr	₹1,058 Cr	₹1,336 Cr	₹723 Cr
Investing	₹-869 Cr	₹-1,292 Cr	₹-725 Cr	₹-855 Cr	₹-521 Cr	₹-510 Cr
Financing	₹-283 Cr	₹-553 Cr	₹507 Cr	₹427 Cr	₹-306 Cr	₹-137 Cr
Free Cash Flow	₹1,683 Cr	₹1,241 Cr	₹1,029 Cr	₹1,058 Cr	₹1,336 Cr	₹723 Cr

Shareholding

Promoter 44.72% Institutions 48.08% Public 7.2%

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search